Clinical trial
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
NCT01748292 is registered in ClinicalTrials.gov with Charles C Wykoff, PhD, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
- Lead sponsor
- Charles C Wykoff, PhD, MD
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2012
- Completion date
- February 28, 2017
- Enrollment
- 60 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.